ImmunoGen Announces Webcast Of Its Analyst And Investor Event On September 18, 2015

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that investors, journalists and the general public are invited to listen to a live webcast of the Company’s analyst and investor community meeting on September 18, 2015.

Help employers find you! Check out all the jobs and post your resume.